XTL Biopharmaceuticals Ltd ADR Capital Reinvestment Ratio

Latest as of December 2019: 0.04x

XTL Biopharmaceuticals Ltd ADR capital reinvestment ratio. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Capital Reinvestment Ratio of 0.04x as of December 2019, meaning it reinvests 0% of its operating cash flow ($1.44 Million) in capital expenditures ($64.00K). Check XTL Biopharmaceuticals Ltd ADR (XTLB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

$1.44 Million

USD

Capital Expenditures

$64.00K

USD

Data as of

Dec 2019

Most recent filing

XTL Biopharmaceuticals Ltd ADR Capital Reinvestment Ratio by Year (None–None)

XTL Biopharmaceuticals Ltd ADR capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of XTL Biopharmaceuticals Ltd ADR.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow